MetaCap

Artivion (AORT) vs OrthoPediatrics (KIDS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

OrthoPediatrics (KIDS) has outperformed Artivion (AORT) over the past year, gaining 77.8% versus a loss of 59.8%. Over five years, AORT leads with a -0.8% price change compared with -45.4% for KIDS. Artivion is the larger company by market cap ($886.0 million vs $828.7 million), about 1.1 times the size, while OrthoPediatrics is growing revenue faster (+15.4% vs +13.6%).

Artivion converts more of its revenue into profit, with a net margin of 2.2% versus -16.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AORT-59.76%KIDS+77.82%
+98%+15%-67%
Nov 21, 20251 yearNov 20, 2026
AORT-4.17%KIDS-48.20%
+157%+36%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AORT versus KIDS key metrics
MetricAORTKIDS
Share price$18.16$31.74
Market cap$886.02M$828.75M
1-day change-2.00%-2.37%
YTD return-60.18%+78.72%
1-year return-59.76%+77.82%
5-year return-0.82%-45.40%
Forward P/E34.92—
EPS (TTM)$-0.36$-1.42
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$441.33M$236.35M
Revenue growth (YoY)+13.59%+15.45%
Net income (latest FY)$9.77M$-39.65M
Gross margin64.40%73.05%
Operating margin7.65%-16.60%
Net margin2.21%-16.78%
52-week high$48.25$34.53
52-week low$18.12$14.42
Distance from 52-week high-62.36%-8.08%
Analyst consensusstrong_buybuy
Avg. price target upside+111.84%+6.74%
Average volume671.97K274.74K
Shares outstanding48.79M26.11M
Employees1,800602
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • KIDS has outperformed AORT by 137.6 percentage points over the past year.
  • Artivion is more profitable, keeping 2.2 cents of every revenue dollar as net income versus -16.8 cents for OrthoPediatrics.

About Artivion

AORT stock →

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.

Health Care · Medical/Dental Instruments · 1,800 employees

About OrthoPediatrics

KIDS stock →

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.

Health Care · Medical/Dental Instruments · 602 employees

AORT vs KIDS FAQ

Which is bigger, Artivion or OrthoPediatrics?

Artivion (AORT) is larger, with a market capitalization of $886.02M compared with $828.75M for OrthoPediatrics (KIDS).

Which stock has performed better over the past year, AORT or KIDS?

KIDS returned +77.82% over the past 12 months, compared with -59.76% for AORT (price return, excluding dividends). Past performance does not predict future results.

Are Artivion and OrthoPediatrics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons